| 000 | 01773 a2200577 4500 | ||
|---|---|---|---|
| 005 | 20250517081023.0 | ||
| 264 | 0 | _c20170206 | |
| 008 | 201702s 0 0 eng d | ||
| 022 | _a1600-0609 | ||
| 024 | 7 |
_a10.1111/ejh.12748 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRobinson, Austin A | |
| 245 | 0 | 0 |
_aRisk of skin cancer in multiple myeloma patients: a retrospective cohort study. _h[electronic resource] |
| 260 |
_bEuropean journal of haematology _cNov 2016 |
||
| 300 |
_a439-444 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 |
_aCombined Modality Therapy _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunocompromised Host |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMultiple Myeloma _xepidemiology |
| 650 | 0 | 4 |
_aNeoplasms, Second Primary _xepidemiology |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aSkin Neoplasms _xepidemiology |
| 700 | 1 | _aWang, James | |
| 700 | 1 | _aVardanyan, Suzie | |
| 700 | 1 | _aMadden, Erik K | |
| 700 | 1 | _aHebroni, Frank | |
| 700 | 1 | _aUdd, Kyle A | |
| 700 | 1 | _aSpektor, Tanya M | |
| 700 | 1 | _aNosrati, Jason D | |
| 700 | 1 | _aKitto, Alex Z | |
| 700 | 1 | _aZahab, Michael | |
| 700 | 1 | _aCheema, Simrin | |
| 700 | 1 | _aFors, Darron H | |
| 700 | 1 | _aNorberg, Adam | |
| 700 | 1 | _aDiehl, Joseph | |
| 700 | 1 | _aWaterman, Gabriel N | |
| 700 | 1 | _aSwift, Regina A | |
| 700 | 1 | _aCrowley, John | |
| 700 | 1 | _aBerenson, James R | |
| 773 | 0 |
_tEuropean journal of haematology _gvol. 97 _gno. 5 _gp. 439-444 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/ejh.12748 _zAvailable from publisher's website |
| 999 |
_c25729012 _d25729012 |
||